Third Cuban Vaccine, Soberana Plus, Approved for Emergency Use

24 September 2021
On Thursday, September 23, the Center for State Control of Medicines, Equipment and Medical Devices (CECMED) approved the Authorization for Emergency Use (AUE) of the Cuban vaccine Soberana Plus, whose holder is the Finlay Vaccine Institute (IFV).
With this authorization, its indication is extended to the COVID-19 convalescent population over 19 years of age, two months or more after their medical discharge from the hospital or at home, in accordance with the regulations and provisions in force, once it has been proven that it meets the requirements in terms of quality, safety and immunogenicity for this population group.
The team of CECMED inspectors is this week carrying out inspections to the clinical sites in Cienfuegos and from there they completed the evaluation process of this vaccine, in order to speed up the vaccination process of all convalescents in the country, informed the Cuban regulatory authority.
Continue reading at www.telesurenglish.net

Cuba Ships First Batch of Abdala COVID-19 Vaccine to Vietnam

24 September 2021
Following last week’s visit of the Vietnamese president to Cuba, a supply agreement for 5 million doses was signed.
BioCubaFarma, the conglomerate of Cuban public enterprises in the biotechnological and pharmaceutical area, sent this Friday to Vietnam the first batch of Abdala anti-viral vaccines, designed by the Center for Genetic Engineering and Biotechnology (CIGB) in Havana.
The information appeared in the social networks of the CIGB itself and although it does not detail the exact number of doses, it is about 15 boxes of 20 kg each, which will be transported in a Vietnam Airlines plane, the flag carrier of the Southeast Asian nation.
Continue reading at www.telesurenglish.net

Read also:
Condamné à perpétuité en Italie pour homicides, l'ex-militant d'extrême gauche Cesare Battisti a été arrêté en Bolivie

We remind our readers that publication of articles on our site does not mean that we agree with what is written. Our policy is to publish anything which we consider of interest, so as to assist our readers  in forming their opinions. Sometimes we even publish articles with which we totally disagree, since we believe it is important for our readers to be informed on as wide a spectrum of views as possible.